<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166944">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00924404</url>
  </required_header>
  <id_info>
    <org_study_id>IRB Protocol #200903757</org_study_id>
    <nct_id>NCT00924404</nct_id>
  </id_info>
  <brief_title>Xylitol Versus Saline in Chronic Sinusitis</brief_title>
  <official_title>Randomized Controlled Trial of Xylitol Versus Saline Rinse For Chronic Sinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this pilot study, the investigators plan to compare the efficacy of twice daily xylitol
      nasal rinse with saline rinse which is the current standard, on outcomes such as quality of
      life and exacerbations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SNOT-20</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>antibiotic use</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>Xylitol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>isotonic xylitol for sinus rinse</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>saline for sinus rinse</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xylitol</intervention_name>
    <description>5% solution for sinus rinse</description>
    <arm_group_label>Xylitol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>saline for sinus rinse</description>
    <arm_group_label>Saline</arm_group_label>
    <other_name>Salt solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        We now have two arms to this study.

        Group I: Immunocompetent subjects with chronic rhinosinusitis

        Inclusion Criteria:

          -  56 Adult subjects (18 or older) presenting to the ENT(ears, nose, throat) clinics who
             meet the diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at
             least 2 of the following 4 signs/symptoms for 12 weeks or longer despite medical
             management:

               -  Anterior and/or posterior mucopurulent drainage

               -  Nasal obstruction

               -  Facial pain, pressure, and/or fullness

               -  Decreased sense of smell

          -  In addition, objective evidence of sinus mucosal disease must be demonstrated on
             sinus CT imaging or direct endoscopic examination.

        Exclusion Criteria:

          -  Cystic fibrosis

          -  Fungal sinusitis

          -  Immunocompromised status (use of long term oral steroids (&gt; 30 days), AIDS, active
             malignancy or chemotherapy)

          -  Known Ciliary disorders

          -  Sinonasal tumors

          -  Pregnancy

        Group 2: CRS with antibody deficiency

          -  56 Adult subjects (18 or older) presenting to the Allergy clinic who meet the
             diagnosis of chronic rhinosinusitis (CRS). Definition of CRS: Presence of at least 2
             of the following 4 signs/symptoms for 12 weeks or longer despite medical management:

               -  Anterior and/or posterior mucopurulent drainage

               -  Nasal obstruction

               -  Facial pain, pressure, and/or fullness

               -  Decreased sense of smell

          -  In addition, objective evidence of sinus mucosal disease must be demonstrated on
             sinus CT imaging or direct endoscopic examination.

        Exclusion criteria:

        Cystic Fibrosis Sinonasal tumors Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lakshmi Durairaj, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 1, 2017</lastchanged_date>
  <firstreceived_date>June 18, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Lakshmi Durairaj</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Xylitol</keyword>
  <keyword>sinusitis</keyword>
  <keyword>Comparing efficacy of twice daily xylitol nasal rinse with saline rinse presently current standard, comparing outcomes like quality of life and exacerbations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
